Additional file 2: of Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Loo, Li; Ailani, Jessica; Schim, Jack; Baygani, Simin; Hundemer, Hans-Peter; Port, Martha; Krege, John

doi:10.6084/m9.figshare.9043553.v1

10194_2019_1032_MOESM2_ESM.docx (16.61 kB)

Additional file 2: of Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

journal contribution

posted on 2019-07-25, 06:26 authored by Li Loo, Jessica Ailani, Jack Schim, Simin Baygani, Hans-Peter Hundemer, Martha Port, John Krege

Table S2. Treatment-emergent adverse events occurred at similar rates in patients using and not using migraine preventive treatments for all doses of lasmiditan. (DOCX 16 kb)

History

Usage metrics

Keywords

Acute treatment Concomitant Ditan Efficacy Lasmiditan Migraine Migraine medication Migraine preventive Migraine prophylaxis

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

History

Usage metrics

Categories

Keywords

Licence

Exports